Documentos clave

Ver Toda la documentación

Saltar a

1708707

USP

Valproic acid

Name: Valproic acid
Brand: USP
Price: 427000 CLP

United States Pharmacopeia (USP) Reference Standard

Sinónimos:

2-Propylpentanoic acid, Valproic acid

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas

Tamaño de envase	SKU	Disponibilidad	Precio
500 mg		Comprobar disponibilidad del carrito	$427.000

Acerca de este artículo

Fórmula lineal:

(CH₃CH₂CH₂)₂CHCO₂H

Número CAS:

99-66-1

Peso molecular:

144.21

NACRES:

NA.24

PubChem Substance ID:

329751478

UNSPSC Code:

41116107

EC Number:

202-777-3

MDL number:

MFCD00002672

$427.000

Comprobar disponibilidad del carrito

Solicite una orden a granel

Servicio técnico

¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.

Permítanos ayudarle

Propiedades

grade

pharmaceutical primary standard

API family

valproic acid

manufacturer/tradename

USP

refractive index

n20/D 1.425 (lit.)

bp

220 °C (lit.)

density

0.9 g/mL at 25 °C (lit.)

application(s)

pharmaceutical (small molecule)

format

neat

SMILES string

CCCC(C(O)=O)CCC

InChI

1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)

InChI key

NIJJYAXOARWZEE-UHFFFAOYSA-N

Gene Information

human ... ALDH5A1(7915)

Descripción

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Valproic acid USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

Divalproex Sodium
Divalproex Sodium Delayed-Release Capsules
Divalproex Sodium Delayed-Release Tablets
Divalproex Sodium Extended-Release Tablets
Valproate Sodium Injection
Valproic Acid
Valproic Acid Capsules

Biochem/physiol Actions

Anticonvulsant that also has efficacy as a mood stabilizer in bipolar disorder

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Other Notes

Sales restrictions may apply.

Comparar elementos similares

Ver comparación completa

Mostrar Diferencias

1 of 1

Este artículo	V0033000	Y0001422	PHR1061
USP 1708707 Valproic acid	V0033000 Valproic acid	Y0001422 Valproic acid for system suitability	Supelco PHR1061 Valproic acid
grade pharmaceutical primary standard	grade pharmaceutical primary standard	grade pharmaceutical primary standard	grade certified reference material, pharmaceutical secondary standard
manufacturer/tradename USP	manufacturer/tradename EDQM	manufacturer/tradename EDQM	manufacturer/tradename -
application(s) pharmaceutical (small molecule)	application(s) pharmaceutical (small molecule)	application(s) pharmaceutical (small molecule)	application(s) pharmaceutical (small molecule)
format neat	format neat	format neat	format neat
Gene Information human ... ALDH5A1(7915)	Gene Information human ... ALDH5A1(7915)	Gene Information human ... ALDH5A1(7915)	Gene Information human ... ALDH5A1(7915)
bp 220 °C (lit.)	bp 220 °C (lit.)	bp 220 °C (lit.)	bp 220 °C (lit.)

Still not finding the right product?

Explore all of our products under Valproic acid

pictograms

GHS08,GHS05,GHS07

signalword

Danger

hcodes

H302,H315,H318,H360FD

pcodes

P202 - P280 - P301 + P312 - P302 + P352 - P305 + P351 + P338 - P308 + P313

Hazard Classifications

Acute Tox. 4 Oral - Eye Dam. 1 - Repr. 1A - Skin Irrit. 2

Clase de almacenamiento

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

flash_point_f

231.8 °F - closed cup

flash_point_c

111 °C - closed cup

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Alterations of neocortical development and maturation in autism: insight from valproic acid exposure and animal models of autism.

Taylor Chomiak et al.

Neurotoxicology and teratology, 36, 57-66 (2012-09-13)

Autism spectrum disorder (ASD) is a behaviourally defined brain disorder affecting approximately 1 in 88 children. Many pathological studies have shown that ASD is frequently associated with grey and white matter changes that can be described by their deviations from

Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder.

Chi-Tso Chiu et al.

Pharmacological reviews, 65(1), 105-142 (2013-01-10)

The mood stabilizers lithium and valproic acid (VPA) are traditionally used to treat bipolar disorder (BD), a severe mental illness arising from complex interactions between genes and environment that drive deficits in cellular plasticity and resiliency. The therapeutic potential of

Adverse drug reactions induced by valproic acid.

Radu M Nanau et al.

Clinical biochemistry, 46(15), 1323-1338 (2013-06-25)

Valproic acid is a widely-used first-generation antiepileptic drug, prescribed predominantly in epilepsy and psychiatric disorders. VPA has good efficacy and pharmacoeconomic profiles, as well as a relatively favorable safety profile. However, adverse drug reactions have been reported in relation with

Ver todos los artículos relacionados

Número de artículo de comercio global

SKU	GTIN
1708707-500MG	04061838750532

Questions

Reviews

No rating value